NanoRepro AG (XTER:NN6) Scaled Net Operating Assets: 0.77 (As of Jun. 2025)


XTER:NN6 NanoRepro AG XTER:NN6
51 GF Score
Price €2.16
GF Value €1.00
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is NanoRepro AG Scaled Net Operating Assets?

NanoRepro AG XTER:NN6 -3.14% 51 Scaled Net Operating Assets is 0.77 as of Jun. 2025. GuruFocus rates XTER:NN6 with a GF Score™ of 51/100 and a GF Value™ of €1.00 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

NanoRepro AG's operating assets for the quarter that ended in Jun. 2025 was €30.70 Mil. NanoRepro AG's operating liabilities for the quarter that ended in Jun. 2025 was €0.69 Mil. NanoRepro AG's Total Assets for the quarter that ended in Dec. 2024 was €39.03 Mil. Therefore, NanoRepro AG's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2025 was 0.77.


NanoRepro AG Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for NanoRepro AG's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NanoRepro AG Scaled Net Operating Assets Chart

NanoRepro AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.70 2.66 0.20 0.40 0.70

NanoRepro AG Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.45 0.32 0.73 0.77

XTER:NN6 vs TMO, DHR, IDXX: Scaled Net Operating Assets Comparison

For the Diagnostics & Research subindustry, NanoRepro AG's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NanoRepro AG Scaled Net Operating Assets vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, NanoRepro AG's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where NanoRepro AG's Scaled Net Operating Assets falls into.


XTER:NN6
51GF Score
NanoRepro AG XTER:NN6
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NanoRepro AG Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

NanoRepro AG's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2024 )
=(Operating Assets (A: Dec. 2024 )-Operating Liabilities (A: Dec. 2024 ))/Total Assets (A: Dec. 2023 )
=(29.927-0.884)/41.458
=0.70

where

Operating Assets(A: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=39.025 - 9.098
=29.927

Operating Liabilities(A: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.884 - 0 - 0
=0.884

NanoRepro AG's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jun. 2025 )
=(Operating Assets (Q: Jun. 2025 )-Operating Liabilities (Q: Jun. 2025 ))/Total Assets (Q: Dec. 2024 )
=(30.702-0.694)/39.025
=0.77

where

Operating Assets(Q: Jun. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=37.992 - 7.29
=30.702

Operating Liabilities(Q: Jun. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.694 - 0 - 0
=0.694

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.77 mean?
NanoRepro AG (XTER:NN6) has a Scaled Net Operating Assets of 0.77 as of Jun. 2025. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on NanoRepro AG and its competitors.
Is NanoRepro AG's Scaled Net Operating Assets too high?
NanoRepro AG's current Scaled Net Operating Assets is 0.77. Overall, NanoRepro AG has a GF Score™ of 51/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NanoRepro AG's Scaled Net Operating Assets compare to TMO and DHR?
NanoRepro AG's Scaled Net Operating Assets of 0.77 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Diagnostics & Research company?
A good Scaled Net Operating Assets depends on the Medical Diagnostics & Research industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on NanoRepro AG and its competitors. NanoRepro AG's current Scaled Net Operating Assets is 0.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NanoRepro AG stock overvalued right now?
Based on GuruFocus' analysis, NanoRepro AG (XTER:NN6) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.00, compared to a current price of €2.16 — trading 116% above its estimated fair value. The current Scaled Net Operating Assets is 0.77. NanoRepro AG's overall GF Score™ is 51/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For NanoRepro AG (XTER:NN6), the current Scaled Net Operating Assets is 0.77 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NanoRepro AG (XTER:NN6) Overvalued in 2026?

Based on GuruFocus' analysis, NanoRepro AG stock appears to be overvalued. The current stock price of €2.16 is trading 116% above its estimated GF Value™ of €1.00. GuruFocus considers NanoRepro AG to be Significantly Overvalued.

Key valuation signals for XTER:NN6:

  • Scaled Net Operating Assets: 0.77
  • GF Value™: €1.00 vs. price of €2.16 (116% above fair value)
  • GF Score™: 51/100 with 6 warning signs

No single metric tells the full story. See the XTER:NN6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


NanoRepro AG Business Description

Address Untergasse 8, Marburg, DEU, 35037
NanoRepro AG is engaged in the development, manufacturing, and distribution of CE-certified rapid diagnostic tests (self-tests) and food supplements for both, home and professional use.
51GF Score

Get the complete analysis for XTER:NN6

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.16
Price
€1.00
GF Value